Do Endometrial Implantation Markers Predict in Vitro Fertilization-Embryo Transfer Cycle Outcomes in Endometriosis Patients Pretreated With Leuprolide Acetate in Depot Suspension?
Phase 4
21 Years
42 Years
21 Years
42 Years
Not Enrolling
Female
Endometriosis, Infertility
Female
Endometriosis, Infertility
Trial Information
Do Endometrial Implantation Markers Predict in Vitro Fertilization-Embryo Transfer Cycle Outcomes in Endometriosis Patients Pretreated With Leuprolide Acetate in Depot Suspension?
See summary
Inclusion Criteria:
- Infertility
- Surgical diagnosis of endometriosis
- Normal ovarian reserve testing
- Regular menses
Exclusion Criteria:
- Irregular menses
- Undiagnosed abnormal uterine bleeding
- Pregnancy
- Prior adverse reaction to any GnRH agonist
- Ovarian cystic or solid mass > 3cm in mean diameter at study entry
- Use of a depot preparation of a GnRh agonist or any hormonal therapy for
endometriosis within 6 months of study entry
- Current hepatic, renal, hematologic or psychiatric disorder
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Ongoing intrauterine pregnancy
Outcome Time Frame:
6-8 weeks after embryo transfer
Safety Issue:
No
Principal Investigator
Eric S Surrey, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Colorado Center for Reproductive Medicine
Authority:
United States: Institutional Review Board
Study ID:
IntegrinIVF
NCT ID:
NCT00621179
Start Date:
March 2003
Completion Date:
February 2008
Related Keywords:
- Endometriosis
- Infertility
- Endometriosis,infertility,in vitro fertilization
- Endometriosis
- Infertility
- Adenoma
Name | Location |
|---|---|
| Colorado Center for Reproductive Medicine | Lone Tree, Colorado 80124 |
